Evidence map›Paper›PMID 10756006›Full record

ArticleJournal of virology2000

Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.

C Retière, V Prod'homme, B M Imbert-Marcille, M Bonneville, H Vié, M M Hallet

Registry-linked trialAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02973464 (The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02973464 unknown statusnot on this mapstarted 2016, after this paper: background citation

The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

TypeobservationalSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityRan2016 to 2019Enrolled450ConditionsRenal Transplant RecipientsArmsValganciclovir, Ganciclovir
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

C RetièreInstitut National de la Santé et de la Recherche Médicale U463, Institut de Biologie, 44093 Nantes Cedex 1, France.
V Prod'homme
B M Imbert-Marcille
M Bonneville
H Vié
M M Hallet
Inserm · FRInstitut de Virologie · FRInstitut National de Recherche en Santé Publique · ML

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytotoxic T lymphocytes (CTLs) play a central role in the control of persistent human cytomegalovirus (HCMV) infection in healthy virus carriers. Previous analyses of the specificity of HCMV-reactive CD8(+) CTLs drawn from in vitro models in which antigen-presenting cells were autologous fibroblasts infected with laboratory HCMV strains have shown focusing of CTL responses against the major tegument protein, pp65. By contrast, the 72-kDa major immediate-early protein (IE1) was identified as a minor target for this response. Here we have studied the fine specificity and T-cell-receptor features of T-cell clones generated against autologous B lymphoblastoid cell lines stably transfected with HCMV cDNA coding for either pp65 or a natural variant of IE1. This strategy allowed efficient generation of T-cell clones against IE1 and pp65 and led to the identification of several new IE1 and pp65 epitopes, including some located in polymorphic regions of IE1. Such an approach may provide relevant information about the characteristics of the CTL response to IE1 and the effect of viral polymorphism on the immune response against HCMV.

Indexed as

Viral ProteinsAllelesAnimalsB-LymphocytesCell Line, TransformedCOS CellsCytomegalovirusEpitopes, T-LymphocyteHistocompatibility Antigens Class IHLA-A2 AntigenHLA-B18 AntigenHLA-B AntigensHumansImmediate-Early ProteinsPhosphoproteinsReceptors, Antigen, T-Cell, alpha-betacytomegalovirus matrix protein 65kDaEpitopes, T-LymphocyteHistocompatibility Antigens Class IHLA-A2 AntigenHLA-B18 AntigenHLA-B AntigensIE1 protein, cytomegalovirusImmediate-Early ProteinsPhosphoproteinsReceptors, Antigen, T-Cell, alpha-betaRecombinant Fusion ProteinsViral Matrix ProteinsViral Proteins

Identifiers

PMID10756006
PMCPMC111908
OpenAlexW2117062643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.